ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
0,00%
(0,00) 1D
13. stu, 17:35:01 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALMKT...
Otvori
0,09 €
Najviša
0,10 €
Najniža
0,09 €
Trž. kap.
18,14 mil.
Prosj. kol.
541,14 tis.
Količina
75,16 tis.
P/E omjer
0,79
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Otvori
0,09 €
Najviša
0,10 €
Najniža
0,09 €
Trž. kap.
18,14 mil.
Prosj. kol.
541,14 tis.
Količina
75,16 tis.
P/E omjer
0,79
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Vijesti
Iz web-izvora i od partnera za vijesti
BigGo Finance
·
prije 56 minuta
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TradingKey
·
prije 11 sati
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
The Motley Fool
·
prije 22 sata
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
StoneX
·
prije 2 dana
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA – informacije
Glavni izvršni direktorSacha Loiseau
Zaposlenici56
Osnovano2000
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijamaunakeatech.com